外周动脉疾病药物治疗的性别差异对发病率的影响
基于血管质量倡议数据库2009至2020年79,981例因外周动脉疾病行腹股沟上或腹股沟下旁路手术的患者,女性占34%。女性术前较少使用血管紧张素转换酶抑制剂、抗凝药和他汀,术后全因发病率、死亡率、卒中和主要不良心血管事件风险均显著高于男性。作者认为关键药物使用减少和合并症负担更重可能是女性发病风险更高的主要原因。
要点
- 女性术前较少使用血管紧张素转换酶抑制剂、抗凝药和他汀。
- 女性术后全因发病率、死亡率、卒中和主要不良心血管事件风险显著高于男性。
- 女性术前未使用他汀对全因发病率的预测作用显著大于男性。
核心结论
- 作者认为外周动脉疾病术后女性患者不良结局风险显著高于男性患者。
- 作者认为女性关键药物(他汀和血管紧张素转换酶抑制剂)使用减少及合并症负担更重可能是其发病风险更高的主要原因。
研究设计与样本
- 回顾性研究,数据提取自血管质量倡议数据库。
- 纳入2009年至2020年因外周动脉疾病行腹股沟上或腹股沟下旁路手术的患者,共79,981例,其中女性占34%。
- 采用二元逻辑回归评估风险预测因素、药物使用特征和术后结局的性别差异,并针对潜在协变量进行调整。
主要发现
- 女性患者就诊年龄通常更大,高血压和糖尿病更常见,术前接受血管紧张素转换酶抑制剂、抗凝药和他汀处方的可能性显著更低。
- 与男性相比,女性术后全因发病风险显著更高(1.06 [1.03, 1.09];P = 0.004)。
- 与男性相比,女性术后死亡风险显著更高(1.09 [1.05, 1.13];P < 0.001)。
- 与男性相比,女性术后卒中风险显著更高(1.48 [1.35, 1.62];P < 0.001)。
- 与男性相比,女性术后主要不良心血管事件风险显著更高(1.19 [1.10, 1.28];P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral artery disease (PAD) has traditionally been identified as a male-dominant disease; however, current literature suggests that female patients may be at increased risk of adverse outcomes. Given the key differences between sexes, we conducted a retrospective review to identify presurgery risk predictors that may increase morbidity within the female PAD population. METHODS: Data were extracted from the Vascular Quality Initiative database for patients who underwent suprainguinal or infrainguinal bypass surgery for PAD between 2009 and 2020. Binary logistic regression was used to assess for sex differences in risk predictors, drug administration characteristics, and postoperative outcomes; analysis was adjusted for potential covariates. RESULTS: A total of 79,981 patients were included based on our eligibility criteria, 34% of which were female. Female patients typically presented at an older age, were more frequently hypertensive and diabetic, and were significantly less likely to be prescribed angiotensin-converting enzyme inhibitors, anticoagulants, and statin preoperatively. Women had a significantly higher postoperative risk of all-cause morbidity (1.06 [1.03, 1.09];P = 0.004), mortality (1.09 [1.05, 1.13];P < 0.001), stroke (1.48 [1.35, 1.62];P < 0.001), and major adverse cardiovascular events (1.19 [1.10, 1.28];P < 0.001) when compared to male patients. No preoperative statin use was a significantly greater predictor for all-cause morbidity in women. CONCLUSION: Following surgery for PAD, our results suggest that female patients have a significantly greater risk of adverse outcomes as compared to male patients. Reduced administration of key medication including statin and angiotensin-converting enzyme inhibitors along with a greater comorbidity burden in female patients may be major contributors to this greater morbidity risk.
引用
- Zhong Q, Ahmed U, Yunus RA, et al. Sex Disparities in Medical Management: Influence on Morbidity in Peripheral Arterial Disease. Ann Vasc Surg. 2025. PMID: 40287128. doi:10.1016/j.avsg.2025.04.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。